Detalhe da pesquisa
1.
First-line trastuzumab plus taxane-based chemotherapy for metastatic breast cancer: cost-minimization analysis.
J Oncol Pharm Pract
; 20(5): 362-8, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24158979